PGRMC1 and metabolic dysfunction-associated steatotic liver disease: PGRMC1 is also implicated in various pathophysiological outcomes such as non-alcoholic fatty liver disease (38), diabetes (39) and cancer (22, 29, 40, 41), which parallel the emerging role of the TPC complex in many of the same disease states (5, 7, 8).